Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker's shares fell after hours as its 2023 guidance fell on the lower end of...
Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker’s shares fell after hours as its 2023 guidance fell on the lower end of Wall Street’s expectations.
Amgen AMGN said it earned $1.6 billion, or $3 a share, in the fourth quarter, compared with $1.89 billion, or $3.26 a share, in the year-ago period. Adjusted for one-time items, Amgen earned $4.40 a share.Analysts polled by FactSet expected the drug maker to report adjusted earnings of $4.10 a share on sales of $6.74 billion.
Amgen said its drug Amjevita, a biosimilar in direct competition with AbbVie Inc.’s ABBV anti-inflamatory drug Humira, is on track. A study to support the drug’s interchangeability designation in the U.S. is ongoing, with a data release scheduled for the first half of the year.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wall Street economist says recession in 2023 will look like biggest crisis of the 1970sPiper Sandler chief global economist Nancy Lazar warns people are too focused on a recession that feels like 2008, when it's more similar to volatility in 1973-74.
Read more »
Tone Shift: 9 Trends from the Fall 2023 Menswear CollectionsIf the past few years represented a departure from tradition, 2023 finds designers eager to rework the classics.
Read more »
The Best Outdoor Playhouses of 2023Whether you’re looking for a wooden outdoor playhouse for kids, a structure with a slide or a miniature pink abode, we’ve got you covered. Check out our favorite outdoor playhouses for all-day fun.
Read more »
Did Sundance 2023 Produce Any Oscar Contenders?V.F.’s awards analysts see potential for Jonathan Majors, Celine Song, Julia Louis-Dreyfus, and others.
Read more »